Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim
External Expert Profile
Adam Hutchings
Latest Publications
How is Quality of Life Measured for Health Technology Assessments?
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?
Read more
© freshidea
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
The Impact of New Medicines in the NHS: 70 Years of Innovation
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
